March News Roundup 

Each month, we round up diabetes-related news and insights from trusted sources to provide you with ideas, tips, education and more to help you live your best life.   

Here’s the latest! 

Can Type 2 Diabetes Be Reversed?

Yale School of Medicine 
Research shows that most cases of type 2 diabetes can be prevented through lifestyle 
interventions. But if you already have the condition, can it be reversed? Read more.

FDA Alerts Patients to Regularly Check Diabetes Device Alert Settings Following Hardware and Software Changes

U.S Food and Drug Administration 
The U.S. Food and Drug Administration (FDA) is alerting patients who use diabetes devices and their caregivers of reports where users of continuous glucose monitors (CGMs), insulin pumps, automated insulin dosing systems, and other diabetes devices did not receive or did not hear alerts from their smartphones. Read more. 

Extreme Heat Can Worsen Diabetes

Harvard T.H Chan School of Public Health 
Rising temperatures driven by climate change could lead to increased health risks for people 
with diabetes. “High temperatures lead to increased heat stress, which worsens glucose control and raises the risk of complications such as foot ulcers and fluctuations in blood sugar levels,” Alahmad told Yale Climate Connections. Read more. 

New UVA Clinical Trial Explores AI-Powered Insulin Delivery for Better Diabetes Care

University of Virigina School of Medicine 
For people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to simplify diabetes management by testing an innovative AI-powered device designed to improve automated insulin delivery. Read more.  

FDA Approves First Rapid-Acting Insulin Biosimilar for Patients with Diabetes

U.S. News and World Report 
“The FDA has now approved three biosimilar insulin products to treat diabetes…today’s approval highlights our continued efforts to improve the efficiency of the biosimilar approval process to help support a competitive marketplace and increase options for costly treatments, like insulin.” Read more.